TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
SVRA

Savara Inc

Healthcare · Biotechnology

5.00$ -5.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SVRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-14.09 -14.22 -2.50 -1.61 -1.18 -1.13 -0.67 -0.30 -0.23 -0.31 -0.45 -0.45
0.05 0.06 0.10 0.02 0.02 0.03 0.01 0.00 0.00 0.00 0.00 0.00
1.16 1.15 0.06 0.03 0.11 0.11 0.09 0.02 0.01 0.03 0.05 0.06
0.88 1.16 1.89 0.13 0.56 0.79 0.17 0.04 – – – –
1.39 1.67 0.45 -0.12 0.07 0.02 -0.03 -0.02 0.01 0.02 0.01 0.02
0.08 0.07 0.00 0.03 0.00 0.00 0.06 0.00 0.00 0.00 0.00 0.00
0.28 1.46 0.00 -3.94 -0.41 0.39 0.15 -0.52 0.34 -0.35 -0.20 -0.08
0.00 0.00 0.00 0.00 – – 0.04 – – – – –
19.61 0.86 5.78 5.21 1.39 1.37 0.04 0.00 0.00 -0.01 -0.01 -0.02
5.72 6.39 -3.52 0.82 0.26 0.00 -0.01 0.00 0.00 0.00 0.00 0.01
19.61 7.25 1.53 6.05 1.66 1.37 0.06 0.90 0.00 0.50 0.59 0.62
5.79 -5.50 -0.99 0.50 0.07 0.64 -0.45 0.08 0.12 -0.15 -0.06 0.08
-14.18 -14.29 -2.50 -1.64 -1.18 -1.13 -0.73 -0.30 -0.23 -0.31 -0.45 -0.45

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?